Oleksiuk-Bójko M, Lisowska A (2023) Venous thromboembolism: why is it still a significant health problem? Adv Med Sci 68(1):10–20. https://doi.org/10.1016/j.advms.2022.10.002

Article  PubMed  Google Scholar 

Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ et al (2021) Antithrombotic therapy for VTE Disease: second update of the CHEST Guideline and Expert Panel Report. Chest 160(6):e545–e608. https://doi.org/10.1016/j.chest.2021.07.055

Article  CAS  PubMed  Google Scholar 

Oesterle A, Laufs U, Liao JK (2017) Pleiotropic effects of statins on the Cardiovascular System. Circ Res 120:229–243. https://doi.org/10.1161/circresaha.116.308537

Article  CAS  PubMed  PubMed Central  Google Scholar 

Undas A, Celińska-Löwenhoff M, Kaczor M, Musial J (2004) New nonlipid effects of statins and their clinical relevance in cardiovascular disease. Thromb Haemost 91:1065–1077. https://doi.org/10.1160/th04-02-0064

Article  CAS  PubMed  Google Scholar 

Undas A, Brummel-Ziedins KE, Mann KG (2005) Statins and blood coagulation. Arterioscler Thromb Vasc Biol. https://doi.org/10.1161/01.atv.0000151647.14923.ec. 25:287 – 94

Article  PubMed  PubMed Central  Google Scholar 

Biedermann JS, Kruip M, van der Meer FJ, Rosendaal FR, Leebeek FWG, Cannegieter SC et al (2018) Rosuvastatin use improves measures of coagulation in patients with venous thrombosis. Eur Heart J 39:1740–1747. https://doi.org/10.1093/eurheartj/ehy014

Article  CAS  PubMed  Google Scholar 

Violi F, Calvieri C, Ferro D, Pignatelli P (2013) Statins as antithrombotic drugs. Circulation 127:251–257. https://doi.org/10.1161/circulationaha.112.145334

Article  PubMed  Google Scholar 

Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr., Kastelein JJ et al (2009) A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 360:1851–1861. https://doi.org/10.1056/nejmoa0900241

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kunutsor SK, Seidu S, Khunti K (2017) Statins and primary prevention of venous thromboembolism a systematic review and meta-analysis. Lancet Haematol 4:e83–e93. https://doi.org/10.1016/s2352-3026(16)30184-3

Article  PubMed  Google Scholar 

Biere-Rafi S, Hutten BA, Squizzato A, Ageno W, Souverein PC, de Boer A et al (2013) Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J 34:1800–1806. https://doi.org/10.1093/eurheartj/eht046

Article  CAS  PubMed  Google Scholar 

Tagalakis V, Eberg M, Kahn S, Azoulay L (2016) Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study. Thromb Haemost 115:1220–1228. https://doi.org/10.1160/th15-10-0775

Article  PubMed  Google Scholar 

Yoshikawa Y, Yamashita Y, Morimoto T, Mabuchi H, Amano H, Takase T et al (2020) Effect of statins on recurrent venous thromboembolism (from the COMMAND VTE Registry). Am J Cardiol 125:189–197. https://doi.org/10.1016/j.amjcard.2019.10.011

Article  CAS  PubMed  Google Scholar 

Delluc A, Tromeur C, Le Moigne E, Nowak E, Mottier D, Le Gal G et al (2012) Lipid lowering drugs and the risk of recurrent venous thromboembolism. Thromb Res 130:859–863. https://doi.org/10.1016/j.thromres.2012.08.296

Article  CAS  PubMed  Google Scholar 

Brækkan SK, Caram-Deelder C, Siegerink B, van Hylckama Vlieg A, le Cessie S, Rosendaal FR et al (2017) Statin use and risk of recurrent venous thrombosis: results from the MEGA follow-up study. Res Pract Thromb Haemost 1:112–119. https://doi.org/10.1002/rth2.12003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaneda K, Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Ikeda N et al (2023) Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants. Eur J Intern Med 118:59–72. https://doi.org/10.1016/j.ejim.2023.08.007

Article  CAS  PubMed  Google Scholar 

Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH et al (2013) Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 369:1406–1415. https://doi.org/10.1056/nejmoa1306638

Article  PubMed  Google Scholar 

Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692–694. https://doi.org/10.1111/j.1538-7836.2005.01204.x

Article  CAS  PubMed  Google Scholar 

Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K et al (2018) Anticoagulation therapy for venous thromboembolism in the Real World　- from the COMMAND VTE Registry. Circ J: Official J Japanese Circulation Soc 82:1262–1270. https://doi.org/10.1253/circj.cj-17-1128

Article  Google Scholar 

Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP et al (2020) 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543–603. https://doi.org/10.1093/eurheartj/ehz405

Article  PubMed  Google Scholar 

Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ et al (2021) Antithrombotic therapy for VTE Disease: second update of the CHEST Guideline and Expert Panel Report. Chest 160:e545–e608. https://doi.org/10.1016/j.chest.2021.07.055

Article  CAS  PubMed  Google Scholar 

Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K et al (2018) Influence of baseline platelet count on outcomes in patients with venous thromboembolism (from the COMMAND VTE Registry). Am J Cardiol 122:2131–2141. https://doi.org/10.1016/j.amjcard.2018.08.053

Article  PubMed  Google Scholar 

Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ et al (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 123:1788–1830. https://doi.org/10.1161/cir.0b013e318214914f

Article  PubMed  Google Scholar 

Ando MFI, Ito M, Kobayashi T, Masuda M, Miyahara Y, Nakanishi N et al (2011) Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). Circ J: Official J Japanese Circulation Soc 75:1258–1281. https://doi.org/10.1253/circj.cj-88-0010

Article  Google Scholar 

Joseph P, Glynn R, Lonn E, Ramasundarahettige C, Eikelboom J, MacFadyen J et al (2022) Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials. Cardiovasc Res 118:897–903. https://doi.org/10.1093/cvr/cvab078

Article  CAS  PubMed  Google Scholar 

Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117:93–102. https://doi.org/10.1161/circulationaha.107.709204

Article  PubMed  Google Scholar 

Zaccardi F, Kunutsor SK, Seidu S, Davies MJ, Khunti K (2018) Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis 271:223–231. https://doi.org/10.1016/j.atherosclerosis.2018.02.035

Article  CAS  PubMed  Google Scholar 

Arshad N, Bjøri E, Hindberg K, Isaksen T, Hansen JB, Braekkan SK (2017) Recurrence and mortality after first venous thromboembolism in a large population-based cohort. J Thromb Haemost 15:295–303. https://doi.org/10.1111/jth.13587

Article  CAS  PubMed  Google Scholar 

Heit JA, Spencer FA, White RH (2016) The epidemiology of venous thromboembolism. J Thromb Thrombolysis 41:3–14. https://doi.org/10.1007/s11239-015-1311-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kronenberg RM, Beglinger S, Stalder O, Méan M, Limacher A, Beer JH et al (2019) Statin therapy and recurrent venous thromboembolism in the elderly: a prospective cohort study. Sci Rep 9:14804. https://doi.org/10.1038/s41598-019-51374-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kunutsor SK, Seidu S, Khunti K (2017) Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies. Eur Heart J 38:1608–1612

Article  PubMed  PubMed Central  Google Scholar 

Zhu H, Zheng H, Xu T, Liu X, Liu X, Sun L et al (2022) Effects of statins in primary and secondary prevention for venous thromboembolism events: a meta analysis. Vascul Pharmacol 142:106931. https://doi.org/10.1093/eurheartj/ehx107

Article  CAS  PubMed  Google Scholar 

Li R, Yuan M, Yu S, Fu W, Yu W, Ling S et al (2021) Effect of statins on the risk of recurrent venous thromboembolism: a systematic review and meta-analysis. Pharmacol Res 165:105413. https://doi.org/10.1016/j.phrs.2020.105413

Article  CAS  PubMed  Google Scholar 

Hemkens LG, Benchimol EI, Langan SM, Briel M, Kasenda B, Januel JM et al (2016) The reporting of studies using routinely collected health data was often insufficient. J Clin Epidemiol 79:104–111. https://doi.org/10.1016/j.jclinepi.2016.06.005

Article  PubMed  PubMed Central